Condition
Adenocarcinoma, Mucinous
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT02005965Unknown
Low Rectal Cancer Study (MERCURY II)
NCT01037049Phase 2Unknown
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
NCT01995942Unknown
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Showing all 3 trials